Blanca is a Healthtech Entrepreneur who deeply cares about eradicating unnecessary human suffering in relation to health. She is a dissenter at heart. She has 25 years of commercial experience, 18 of which she's spent in life sciences senior commercial leadership roles, including Big Pharma, Biotech and AI tech applied to biomedicine, drug development and point of care. She's worked across geographies (North America, Europe and Asia), a myriad of therapeutic and disease areas, and across the whole lifecycle of drug treatments.
17 months ago, she set up her own business, DBounce - a Spotify for patient data in chronic diseases, to change the paradigm on how we collect and include patient self-reported data in precision medicine research and personalized clinical decision making. Before founding her current business, she created, led and grew a new business unit through leveraging data assets and AI and bioinformatics tech to serve drug R&D and commercialization through SaaS-packaged algorithms and in-silico models and services. She is a translator of scientific breakthroughs into innovative business models. Negotiator. Strategist. Commercial, business development, and disruption-adoption expert. She's also a chronic disease patient herself. She holds an MBA from London Business School, and further executive and scientific education from Wharton Business School and Harvard Medical School.
17 months ago, she set up her own business, DBounce - a Spotify for patient data in chronic diseases, to change the paradigm on how we collect and include patient self-reported data in precision medicine research and personalized clinical decision making. Before founding her current business, she created, led and grew a new business unit through leveraging data assets and AI and bioinformatics tech to serve drug R&D and commercialization through SaaS-packaged algorithms and in-silico models and services. She is a translator of scientific breakthroughs into innovative business models. Negotiator. Strategist. Commercial, business development, and disruption-adoption expert. She's also a chronic disease patient herself. She holds an MBA from London Business School, and further executive and scientific education from Wharton Business School and Harvard Medical School.
Speaking In
9:00 AM - 10:00 AM
Thursday, June 8